These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2627595)

  • 1. Donor characteristics in allogeneic bone marrow transplantation.
    Zupancić-Salek S; Aurer I; Bogdanić V; Nemet D; Mrsić M; Labar B
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():107. PubMed ID: 2627595
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunodeficiency after allogeneic bone marrow transplantation in man: the role of antigen presenting cells.
    Møller J; Dickmeiss E; Jacobsen N; Svejgaard A
    Tokai J Exp Clin Med; 1996 Feb; 21(1):13-7. PubMed ID: 9239799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation.
    Avital I; Moreira AL; Klimstra DS; Leversha M; Papadopoulos EB; Brennan M; Downey RJ
    Stem Cells; 2007 Nov; 25(11):2903-9. PubMed ID: 17690178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of cryopreserved bone marrow in unrelated allogeneic transplantation.
    Stockschläder M; Krüger W; tom Dieck A; Horstmann M; Altnöder M; Löliger C; Fiedler W; Hoffknecht M; Erttmann R; Zander A
    Bone Marrow Transplant; 1996 Feb; 17(2):197-9. PubMed ID: 8640166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell salvage and reinfusion in pediatric bone marrow donors.
    Kletzel M; Olszewski M; Danner-Koptik K; Coyne K; Haut P
    Bone Marrow Transplant; 1999 Aug; 24(4):385-8. PubMed ID: 10467327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
    Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow grafts from unrelated donors].
    Esperou-Bourdeau H
    Rev Prat; 1994 Sep; 44(14):1851-4. PubMed ID: 7939273
    [No Abstract]   [Full Text] [Related]  

  • 9. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
    Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
    Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cytomegalovirus-infected cells in bone marrow biopsy specimens obtained before allogeneic bone marrow transplantation from donors and recipients.
    Fest T; Angonin R; Mougin C; Deschaseaux M; Lab M; Cahn JY; Herve P
    Transplantation; 1994 Jun; 57(11):1681-3. PubMed ID: 8009607
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia.
    Passweg JR; Pérez WS; Eapen M; Camitta BM; Gluckman E; Hinterberger W; Hows JM; Marsh JC; Pasquini R; Schrezenmeier H; Socié G; Zhang MJ; Bredeson C
    Bone Marrow Transplant; 2006 Apr; 37(7):641-9. PubMed ID: 16489361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation: prospects for leukemia and other conditions.
    Thomas ED
    Proc Inst Med Chic; 1975; 30(8):256-8. PubMed ID: 1103123
    [No Abstract]   [Full Text] [Related]  

  • 14. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.
    Gahrton G; Iacobelli S; Bandini G; Björkstrand B; Corradini P; Crawley C; Hegenbart U; Morgan G; Kröger N; Schattenberg A; Schönland SO; Verdonck LF; Volin L; de Witte T; Niederwieser D;
    Haematologica; 2007 Nov; 92(11):1513-8. PubMed ID: 18024400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation.
    Singhal S; Powles R; Kulkarni S; Treleaven J; Sirohi B; Millar B; Shepherd V; Saso R; Rowland A; Long S; Cabral S; Horton C; Mehta J
    Bone Marrow Transplant; 2000 Mar; 25(5):501-5. PubMed ID: 10713626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation using unrelated marrow donors.
    Fay JW; Collins RH; Piñeiro L
    Bone Marrow Transplant; 1993; 11 Suppl 1():81-2. PubMed ID: 8448557
    [No Abstract]   [Full Text] [Related]  

  • 17. Marrow donor registry and bone marrow transplantation from unrelated donors in Taiwan: initial experience of the Tzu Chi Taiwan Marrow Donor Registry (TCTMDR).
    Shaw CK; Lin CL; Li CC; Lee TD; Tseng WP
    Bone Marrow Transplant; 1999 Apr; 23(7):727-30. PubMed ID: 10218851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission.
    Lee SH; Lee MH; Lee JH; Min YH; Lee KH; Cheong JW; Lee J; Park KW; Kang JH; Kim K; Kim WS; Jung CW; Choi SJ; Lee JH; Park K
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):122-8. PubMed ID: 15682073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a closed system for V alpha beta-positive T cell depletion of marrow for use in partially mismatched related donor (PMRD) transplantation.
    Lee C; Brouillette M; Lamb L; Pati A; Brown S; Thompson J; Parrish R; Henslee-Downey PJ; Gee AP
    Prog Clin Biol Res; 1994; 389():523-32. PubMed ID: 7700917
    [No Abstract]   [Full Text] [Related]  

  • 20. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia.
    Lawler M; Locasciulli A; Longoni D; Schiro R; McCann SR
    Bone Marrow Transplant; 2002 Mar; 29(5):453-6. PubMed ID: 11919737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.